Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CENTRE ETD IND PHARMA
Centre dEtudes pour lIndustrie Pharmaceutique
Original Assignee
CENTRE ETD IND PHARMA
Centre dEtudes pour lIndustrie Pharmaceutique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CENTRE ETD IND PHARMA, Centre dEtudes pour lIndustrie PharmaceutiquefiledCriticalCENTRE ETD IND PHARMA
Priority to FR7400945ApriorityCriticalpatent/FR2257271A1/fr
Publication of FR2257271A1publicationCriticalpatent/FR2257271A1/fr
Application grantedgrantedCritical
Publication of FR2257271B1publicationCriticalpatent/FR2257271B1/fr
C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
C07D495/04—Ortho-condensed systems
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur
(AREA)
FR7400945A1974-01-111974-01-11Thieno- or furo-(3,2-c) pyridinium salt contg compsns - for use as antiarrhythmics esp by oral admin
GrantedFR2257271A1
(en)